From Centre for Chronic Disease Control, Gurgaon, India (D.P., P.J.); Centre for Control of Chronic Conditions, Public Health Foundation of India, Gurgaon, India (D.P., P.J.); and All India Institute of Medical Sciences, New Delhi, India (A.R.).
Circulation. 2016 Apr 19;133(16):1605-20. doi: 10.1161/CIRCULATIONAHA.114.008729.
Cardiovascular diseases (CVDs) have now become the leading cause of mortality in India. A quarter of all mortality is attributable to CVD. Ischemic heart disease and stroke are the predominant causes and are responsible for >80% of CVD deaths. The Global Burden of Disease study estimate of age-standardized CVD death rate of 272 per 100 000 population in India is higher than the global average of 235 per 100 000 population. Some aspects of the CVD epidemic in India are particular causes of concern, including its accelerated buildup, the early age of disease onset in the population, and the high case fatality rate. In India, the epidemiological transition from predominantly infectious disease conditions to noncommunicable diseases has occurred over a rather brief period of time. Premature mortality in terms of years of life lost because of CVD in India increased by 59%, from 23.2 million (1990) to 37 million (2010). Despite wide heterogeneity in the prevalence of cardiovascular risk factors across different regions, CVD has emerged as the leading cause of death in all parts of India, including poorer states and rural areas. The progression of the epidemic is characterized by the reversal of socioeconomic gradients; tobacco use and low fruit and vegetable intake have become more prevalent among those from lower socioeconomic backgrounds. In addition, individuals from lower socioeconomic backgrounds frequently do not receive optimal therapy, leading to poorer outcomes. Countering the epidemic requires the development of strategies such as the formulation and effective implementation of evidence-based policy, reinforcement of health systems, and emphasis on prevention, early detection, and treatment with the use of both conventional and innovative techniques. Several ongoing community-based studies are testing these strategies.
心血管疾病(CVDs)现在已成为印度的主要死亡原因。四分之一的死亡归因于 CVD。缺血性心脏病和中风是主要病因,占 CVD 死亡人数的>80%。全球疾病负担研究估计,印度每 10 万人中有 272 人死于 CVD,高于全球每 10 万人中有 235 人死于 CVD 的平均水平。印度 CVD 流行的某些方面尤其令人担忧,包括其加速发展、人口发病年龄较早以及高病死率。在印度,从以传染病为主向非传染性疾病的流行病学转变发生在相当短的时间内。由于 CVD,印度过早死亡(以失去的生命年数衡量)增加了 59%,从 1990 年的 2320 万人增加到 2010 年的 3700 万人。尽管不同地区心血管危险因素的流行情况存在广泛的异质性,但 CVD 已成为印度所有地区(包括较贫困的州和农村地区)的主要死亡原因。该流行的进展特点是社会经济梯度的逆转;来自较低社会经济背景的人烟草使用和水果及蔬菜摄入量较低的情况更为普遍。此外,来自较低社会经济背景的个体通常无法接受最佳治疗,导致预后较差。应对这一流行需要制定策略,例如制定和有效实施循证政策、加强卫生系统以及强调预防、早期发现和使用传统及创新技术进行治疗。目前正在进行的几项社区研究正在测试这些策略。